Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWaldemar Link GmbH & Co. KG
About this trial
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results.
The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
Eligibility criteria
Qualifiers
Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link
Age ≥ 18 years
Fully signed patient informed cons
Disqualifiers
Revisions
Body Mass Index (BMI) ≥ 40 kg/m²
Patient who is foreseeable not able to understand the study and the study-related circumstances
Patients who is foreseeable non-compliant to the treatment and the follow-ups
Trial design
Treatments tested in this trial
- MobileLink
Treatment groups
No treatment groups listed
Locations
2Germany
Lubinus Stiftung Kiel Germany
United Kingdom
NHS FIFE Victoria Hospital Kirkcaldy United Kingdom
Sponsors and collaborators
Waldemar Link GmbH & Co. KG
Lead sponsor
Source ClinicalTrials.gov